Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, with standalone net profit of Rs 370.99 crore for Q4 and Rs 837.55 crore for FY.
Recommended final dividend of 200% (Rs 4 per share), bringing total FY26 dividend to 560% (Rs 11.20 per share), subject to shareholder approval at AGM on August 18, 2026.
Approved financial assistance of up to Rs 100 crore to subsidiary Hindusthan Specialty Chemicals for capacity expansion and cancellation of 39 lakh forfeited equity shares.
Report includes unmodified audit opinion from Deloitte Haskins & Sells and declaration of compliance with SEBI regulations.